[Immunotherapy of cancer using levamisole, immunologic control of the post-surgical patient and graphic follow-up].
The continuous administration of levamisole for immunological stimulation after breast cancer surgery increases life expectancy significantly.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000601:surgery; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000601:surgery; D004137:Dinitrochlorobenzene; D005260:Female; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D011897:Random Allocation
D000276:Adjuvants, Immunologic; D004137:Dinitrochlorobenzene; D007978:Levamisole
La inmunoterápia del cáncer mediante levamisol, control immunológico del paciente post-quirúrgico y su seguimiento gráfico.